Arvada, Colorado Clinical Trials

A listing of Arvada, Colorado clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 33 clinical trials
Enfortumab Vedotin and Pembrolizumab With or Without Chemotherapy vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer

This study is being done to see how well two drugs (enfortumab vedotin and pembrolizumab) work together alone or with platinum chemotherapy to treat patients with urothelial cancer. The study will compare these drugs to other drugs that are usually used to treat this cancer (standard of care). The patients …

cancer
enfortumab vedotin
gemcitabine
pd-l1
cisplatin
Cancer Centers of Colorado - Denver
 (7.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +25 other locations
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.

ventricular septal defects
heart disease
left ventricular end-diastolic pressure
ventricular septal defect
atrial septal defect
National Jewish Health
 (8.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +210 other locations
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors (KEYNOTE-A04)

Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcRIIB), in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors Previously Treated with Anti-PD-1 or Anti-PD-L1 Antibodies

cancer
solid tumour
pd-l1
advanced solid tumor
lung cancer
Sarah Cannon Research Institute
 (7.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +7 other locations
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

Colorado Blood Cancer Institute (CBCI)
 (7.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

pd-l1
HIV Infection
cisplatin
immunohistochemistry
carboplatin
National Jewish Health-Northern Hematology Oncology
 (6.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +358 other locations
SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"  

Primary Objective: To evaluate the effect of dupilumab on sleep quality in adult patients with moderate to severe atopic dermatitis (AD) Secondary Objectives: To evaluate the effect of dupilumab on objective and subjective quantitative sleep parameters, AD related outcomes, and daytime consequences of sleep deprivation To continue to assess the …

corticosteroids
dupilumab
atopic
dermatitis
sleep disturbances
Investigational Site Number 8400005
 (8.7 away)
  • 0 views
  • 19 Feb, 2024
  • +41 other locations
None

Rocky Mountain Cancer Centers - Aurora
 (7.8 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.

cancer
measurable disease
rimiducid
castration-resistant prostate cancer
prostate cancer
Sarah Cannon Research Institute at HealthONE
 (7.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +2 other locations
None

Rocky Mountain Cancer Centers - Aurora
 (7.8 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

Rocky Mountain Cancer Centers - Aurora
 (7.8 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations